# Physiological Study of the Human CYP3A Activity (PiSA)

> **NCT03204578** · PHASE4 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 12 (actual)

## Conditions studied

- Cytochrome P450 CYP3A Enzyme Deficiency

## Interventions

- **DRUG:** AB (Midazolam OD formulation/Dormicum)
- **DRUG:** BA (Dormicum/Midazolam OD formulation)

## Key facts

- **NCT ID:** NCT03204578
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-18
- **Primary completion:** 2017-09-25
- **Final completion:** 2017-09-25
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204578, "Physiological Study of the Human CYP3A Activity (PiSA)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03204578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*